Wednesday, July 18, 2018

Johnson & Johnson on Tuesday reported better-than-expected second quarter profit as sales of pharmaceuticals surged 20 percent despite a sharp decline in blockbuster arthritis drug Remicade, and its shares rose more than 4 percent.


from Reuters: Health News https://ift.tt/2LtkMo7

Related Posts:

  • LATEST HEALTH NEWSChina's Xiamen Airlines has reversed a short-lived ban and resumed serving pork on flights after a "misunderstanding" about the measures being taken to tackle African swine fever, the deadly disease sweeping China's pig herd.… Read More
  • LATEST HEALTH NEWSZafgen Inc said on Monday the U.S. Food and Drug Administration had placed a clinical hold on U.S. trials of its experimental diabetes drug, citing possible heart safety risks. from Reuters: Health News https://ift.tt/2R… Read More
  • LATEST HEALTH NEWSBritain's Vectura Group Plc will stop developing its treatment for severe uncontrolled asthma after a trial showed it failed to have a significant impact on the condition. from Reuters: Health News https://ift.tt/2r7mXFz… Read More
  • LATEST HEALTH NEWSChinese health and medical ethics authorities started an investigation on Monday into claims by a scientist who released videos on YouTube saying he had altered the genes of twins born earlier this month, creating the first g… Read More
  • LATEST HEALTH NEWSSouth African drugmaker Aspen Pharmacare on Monday launched a triple-combination tablet for the treatment of HIV in the country where the virus is most prevalent. from Reuters: Health News https://ift.tt/2Kz4Y3K … Read More

0 comments:

Post a Comment

Followers

Contact Form

Name

Email *

Message *

Popular Posts

FOLLOW BY EMAIL

Enter your email address:

Delivered by FeedBurner